deltatrials
Not Yet Recruiting NA INTERVENTIONAL 1-arm NCT06755359

Alpha Radiation Emitters Device (DaRT) for the Treatment of Locally Advanced Pancreatic Cancer

A Safety Study of Intratumoral Diffusing Alpha Radiation Emitters With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer

Sponsor: Alpha Tau Medical LTD.

Conditions Locally Advanced Pancreatic Cancer Pancreatic Cancer
Interventions Radiation: Diffusing Alpha Radiation Emitters Therapy (DaRT)
Updated 3 times since 2025 Last updated: Dec 1, 2025 Started: Jan 31, 2026 Primary completion: Jan 31, 2027 Completion: Jun 30, 2027
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Locally Advanced Pancreatic Cancer and Pancreatic Cancer, this trial is actively recruiting participants. The trial is conducted by Alpha Tau Medical LTD. and has accumulated 3 data snapshots since 2026. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.

Status Flow

~Feb 2025 – ~Mar 2025 · 28 days · monthly snapshot~Mar 2025 – ~Jan 2026 · 10 months · monthly snapshotNot Yet Recruiting~Jan 2026 – present · 6 months · monthly snapshotNot Yet Recruiting

Change History

3 versions recorded

  1. Jan 2026 — Present [monthly]

    Not Yet Recruiting NA

  2. Mar 2025 — Jan 2026 [monthly]

    Not Yet Recruiting NA

  3. Feb 2025 — Mar 2025 [monthly]

    Not Yet Recruiting NA

    First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Alpha Tau Medical LTD.
Data source: Alpha Tau Medical LTD.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations